Genetic Technologies Newswire

Genetic Technologies Newswire

Comprehensive Real-Time News Feed for Genetic Technologies.

Results 1 - 20 of 29 in Genetic Technologies

  1. Genetic Technologies (GENE) Getting Somewhat Positive News Coverage, Study ShowsRead the original story w/Photo

    Tuesday | Daily Political

    Media coverage about Genetic Technologies has trended somewhat positive on Tuesday, Accern Sentiment Analysis reports. The research firm scores the sentiment of news coverage by analyzing more than twenty million news and blog sources in real time.

    Comment?

  2. Genetic Technologies Limited Breast Cancer Awareness Month Promotion For BREVAGenplusRead the original story

    Monday Jul 31 | BioSpace

    Genetic Technologies Limited , a molecular diagnostics company specialising in cancer genomics, and provider of BREVAGenplus , a first-in-class, clinically validated risk assessment test for non-hereditary breast cancer, announced today that commencing on 1 August, the Company will launch a three month promotional campaign in conjunction with Breast Cancer Awareness Month which takes place throughout October 2017. As part of the initiative, the BREVAGenplus test will be offered at a special reduced price of $199.00 compared to its standard list price of $349.00.

    Comment?

  3. Genetic Technologies Launches Breast Cancer Awareness Month Promotion for BREVAGenplusRead the original story w/Photo

    Tuesday Aug 1 | Market Wire

    ... direct-pay program," commented Eutillio Buccilli, Executive Director and Chief Executive Officer of Genetic Technologies. In April 2017, Genetic Technologies completed a commercial repositioning and repricing of BREVAGen plus whereby the Company ...

    Comment?

  4. Genetic Technologies Limited: Quarterly Activities Report And...Read the original story

    Thursday Jul 27 | BioSpace

    Genetic Technologies Limited : Quarterly Activities Report And Appendix 4C Of The ASX Listing Rules For The Quarter Ended 30 June 2017 Genetic Technologies Limited , a molecular diagnostics company focused on cancer risk assessment, and provider of BREVAGenplus , a first-in-class, clinically validated risk assessment test for non-hereditary breast cancer, is pleased to provide its Quarterly Activities Report for the period ending 30 June 2017, together with the attached Appendix 4C. "I'm particularly pleased with the progress achieved across the commercial and product development fronts.

    Comment?

  5. Genetic Technologies (GENE) Receives News Sentiment Score of 0.13Read the original story w/Photo

    Wednesday Jul 19 | IntersportsWire

    News headlines about Genetic Technologies have trended somewhat positive this week, Accern Sentiment reports. The research firm identifies positive and negative media coverage by reviewing more than 20 million blog and news sources in real time.

    Comment?

  6. Genetic Technologies (GENE) Receives Daily News Impact Score of 0.13Read the original story w/Photo

    Jul 4, 2017 | IntersportsWire

    News stories about Genetic Technologies have trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm rates the sentiment of media coverage by analyzing more than 20 million blog and news sources.

    Comment?

  7. Genetic Technologies (NASDAQ:GENE) Given Media Sentiment Rating of 0.31Read the original story w/Photo

    Jul 3, 2017 | The Breeze

    News coverage about Genetic Technologies has trended positive recently, Accern Sentiment Analysis reports. The research firm identifies negative and positive media coverage by analyzing more than 20 million blog and news sources in real time.

    Comment?

  8. Genetic Technologies (GENE) Earns Media Impact Rating of 0.13Read the original story w/Photo

    Jun 24, 2017 | IntersportsWire

    Media stories about Genetic Technologies have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm scores the sentiment of media coverage by analyzing more than twenty million blog and news sources in real time.

    Comment?

  9. Gisborne stores high-yielding investmentRead the original story w/Photo

    Jun 16, 2017 | The New Zealand Herald

    ... areas, offices, two plant rooms, and storage and staff facilities, Nankervis says. Current tenants are Genetic Technologies, which produces and markets the Pioneer seed brand in New Zealand; Cedenco Foods New Zealand, which produces and exports ...

    Comment?

  10. Genetic Technologies Limited (GENE) Receives Coverage Optimism Score of 0.42Read the original story w/Photo

    May 5, 2017 | Daily Political

    Media coverage about Genetic Technologies Limited has trended positive recently, Alpha One Sentiment Analysis reports. The research group, a service of Accern, identifies positive and negative media coverage by analyzing more than 20 million news and blog sources in real-time.

    Comment?

  11. Genetic Technologies Limited (GENE) Receives News Impact Rating of 0.10Read the original story w/Photo

    May 2, 2017 | Daily Political

    Media headlines about Genetic Technologies Limited have trended somewhat positive this week, Alpha One reports. The research firm, a division of Accern, identifies negative and positive press coverage by analyzing more than 20 million blog and news sources in real-time.

    Comment?

  12. Genetic Technologies Limited (GENE) Receiving Somewhat Favorable News Coverage, Report ShowsRead the original story w/Photo

    Apr 25, 2017 | AmericanBankingNews.com

    Headlines about Genetic Technologies Limited have trended somewhat positive this week, Alpha One Sentiment reports. The research firm, a subsidiary of Accern, identifies positive and negative press coverage by reviewing more than 20 million news and blog sources.

    Comment?

  13. Genetic Technologies Limited (GENE) Receives Daily Media Sentiment Rating of -0.12Read the original story w/Photo

    Apr 18, 2017 | AmericanBankingNews.com

    Media headlines about Genetic Technologies Limited have trended somewhat negative on Tuesday, Alpha One Sentiment Analysis reports. Alpha One, a subsidiary of Accern, scores the sentiment of media coverage by monitoring more than 20 million blog and news sources in real-time.

    Comment?

  14. Genetic Technologies Limited (GENE) Given Daily News Impact Score of 0.01Read the original story w/Photo

    Apr 15, 2017 | Daily Political

    Media headlines about Genetic Technologies Limited have trended somewhat positive recently, AlphaOne Sentiment reports. The research group, a subsidiary of Accern, identifies negative and positive media coverage by monitoring more than 20 million blog and news sources.

    Comment?

  15. Genetic Technologies Limited (GENE) Receives Daily News Sentiment Score of 0.16Read the original story w/Photo

    Apr 9, 2017 | AmericanBankingNews.com

    News stories about Genetic Technologies Limited have trended somewhat positive on Sunday, according to AlphaOne Sentiment Analysis. The research firm, a unit of Accern, ranks the sentiment of media coverage by analyzing more than twenty million blog and news sources.

    Comment?

  16. Genetic Technologies Limited (GENE) Receives Daily News Sentiment Score of 0.16Read the original story w/Photo

    Apr 9, 2017 | The Breeze

    News articles about Genetic Technologies Limited have been trending somewhat positive recently, according to Alpha One. The research group, a unit of Accern, rates the sentiment of press coverage by reviewing more than twenty million news and blog sources in real-time.

    Comment?

  17. Genetic Technologies Limited (GENE) Getting Somewhat Positive News Coverage, Study ShowsRead the original story w/Photo

    Apr 6, 2017 | IntersportsWire

    Media stories about Genetic Technologies Limited have been trending somewhat positive this week, Alpha One reports. Alpha One, a division of Accern, scores the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time.

    Comment?

  18. Genetic Technologies Limited Revamps Patient Pricing And Billing Program For BREVAGenplusRead the original story

    Apr 2, 2017 | BioSpace

    ... number of physicians using BREVAGen plus ," commented Mr. Eutillio Buccilli, Chief Executive Officer of Genetic Technologies Limited. "We have been monitoring the issue of payment for a considerable period of time and have observed how other MDx ...

    Comment?

  19. Genetic Technologies Revamps Patient Pricing and Billing Program for BREVAGenplusRead the original story

    Mar 31, 2017 | World News Report

    ... number of physicians using BREVAGen plus ," commented Mr. Eutillio Buccilli, Chief Executive Officer of Genetic Technologies Limited. "We have been monitoring the issue of payment for a considerable period of time and have observed how other MDx ...

    Comment?

  20. Genetic Technologies: Catalysts For Tremendous UpsideRead the original story w/Photo

    Dec 28, 2016 | Seeking Alpha

    ... revolutionize the way this cancer is detected. Needless to say, this could be a market worth billions. Genetic Technologies is expected to post its validation study for the test within six months. The publishing of this test is a huge near-term ...

    Comment?